Please use this identifier to cite or link to this item:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

A novel role for the tumor suppressor gene ITF2 in tumorigenesis and chemotherapy response

AuthorsPernía, Olga CSIC; Sastre-Perona, Ana CSIC; Rodriguez-Antolín, Carlos; García-Guede, Alvaro; Palomares, María; Rosas, Rocio; Sanchez-Cabrero, Darío; Cruz, Patricia; Rodríguez, Carmen ; Diestro, M. Dolores; Martín-Arenas, Rubén; Pulido, Veronica; Santisteban, Pilar CSIC ORCID; Castro Carpeño, Javier de; Vera Puente, Olga; Ibáñez de Cáceres, Inmaculada CSIC ORCID
KeywordsWnt pathway
Chemotherapy resistance
Issue Date2020
PublisherMultidisciplinary Digital Publishing Institute
CitationCancers 12(4): 786 (2020)
AbstractDespite often leading to platinum resistance, platinum-based chemotherapy continues to be the standard treatment for many epithelial tumors. In this study we analyzed and validated the cytogenetic alterations that arise after treatment in four lung and ovarian paired cisplatin-sensitive/resistant cell lines by 1-million microarray-based comparative genomic hybridization (array-CGH) and qRT-PCR methodologies. RNA-sequencing, functional transfection assays, and gene-pathway activity analysis were used to identify genes with a potential role in the development of this malignancy. The results were further explored in 55 lung and ovarian primary tumors and control samples, and in two extensive in silico databases. Long-term cell exposure to platinum induces the frequent deletion of ITF2 gene. Its expression re-sensitized tumor cells to platinum and recovered the levels of Wnt/β-catenin transcriptional activity. ITF2 expression was also frequently downregulated in epithelial tumors, predicting a worse overall survival. We also identified an inverse correlation between ITF2 and HOXD9 expression, revealing that Non-small cell lung cancer (NSCLC) patients with lower expression of HOXD9 had a better overall survival rate. We defined the implication of ITF2 as a molecular mechanism behind the development of cisplatin resistance probably through the activation of the Wnt-signaling pathway. This data highlights the possible role of ITF2 and HOXD9 as novel therapeutic targets for platinum resistant tumors.
DescriptionThis article belongs to the Special Issue Non-small Cell Lung Cancer—Tumor Biology.
Publisher version (URL)
Appears in Collections:(IIBM) Artículos

Files in This Item:
File Description SizeFormat
anoverespon.pdf3,03 MBAdobe PDFThumbnail
Show full item record
Review this work


checked on Nov 23, 2021

Google ScholarTM




WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.